OSE Immunotherapeutics SA (EPA:OSE)
4.300
-0.088 (-2.01%)
At close: Feb 20, 2026
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €96.41 million as of February 20, 2026. Its market cap has decreased by -37.30% in one year.
Market Cap
96.41M
Enterprise Value
104.26M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.30
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has decreased from 104.30M to 96.41M, a decrease of -7.57%. That is a compound annual growth rate of -0.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 96.41M | -16.50% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 245.91M |
| Transgene | 225.09M |
| MaaT Pharma | 144.51M |
| Adocia | 137.15M |
| Innate Pharma | 131.78M |
| ABIONYX Pharma | 118.36M |
| Sensorion | 94.91M |
| Valerio Therapeutics Société anonyme | 72.11M |